Aaron Bloomer compensation by year
EXACT SCIENCES Summary Compensation Table · the one fiscal year held| Component | FY2024 |
|---|---|
| Salary | $431,868 |
| Bonus | $600,000 |
| Stock awards | $6,002,837 |
| Option awards | $0 |
| Non-equity incentive | $136,662 |
| Pension and deferred compensation | $0 |
| All other | $15,421 |
| Total | $7,186,788 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: EXACT SCIENCES CORP DEF 14A filed April 29, 2025, accession 0001124140-25-000034, and prior-year filings. Open the filing on EDGAR.
How this page was built: the EXACT SCIENCES CORP filed document, accession 0001124140-25-000034. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 58,784 | $3,303,073 | — |
| RSU | 51,619 | $2,900,472 | — |
| RSU | 11,556 | $649,332 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in EXACT SCIENCES CORP's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
12 Form 4 lines since the FY2024 proxy (filed April 29, 2025)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-03-23 | Disposition to the issuer derivative | — | 4,395 | — | 0 |
| 2026-03-23 | Disposition to the issuer derivative | — | 28,063 | — | 0 |
| 2026-03-23 | Grant or award | — | 89,911 | $0.00 | 138,679 |
| 2026-03-23 | Disposition to the issuer | — | 138,679 | — | 0 |
| 2026-03-23 | Disposition to the issuer | — | 417 | — | 0 |
| 2026-02-25 | Grant or award derivative | — | 28,063 | $0.00 | 28,063 |
| 2025-12-23 | Exercise or conversion derivative | — | 38,715 | $0.00 | 0 |
| 2025-12-23 | Exercise or conversion | — | 38,715 | $0.00 | 52,338 |
The 8 most recent of 12 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
EXACT SCIENCES’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Kevin Conroy | Chairman, President and Chief Executive Officer | $15,539,378 |
| Aaron Bloomer · this page | Executive Vice President and Chief Financial Officer | $7,186,788 |
| Jacob Orville | Executive Vice President and General Manager, Screening | $4,433,192 |
| Brian Baranick | Executive Vice President and General Manager, Precision Oncology | $4,399,668 |
| Everett Cunningham | Former Executive Vice President and Former Chief Commercial Officer | $4,141,654 |
| Jeffrey Elliott | Former Executive Vice President and Former Chief Financial Officer | $3,221,441 |
| Sarah Condella | Executive Vice President, Human Resources | $2,645,555 |
Aaron Bloomer's compensation dossier, EXACT SCIENCES
You have read Aaron Bloomer's totals and holdings. The dossier adds each equity grant EXACT SCIENCES disclosed for Aaron Bloomer and EXACT SCIENCES's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full EXACT SCIENCES compensation record
free company briefThis page is one person within EXACT SCIENCES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the EXACT SCIENCES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order EXACT SCIENCES's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are EXACT SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order EXAS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.